Thanks Steve. The statement that they have funding from a variety of non-dilutive sources is welcome. I am somewhat surprised that they did not mention the recent developments in China, however that may have more to do with what you asked than anything else.
My thinking was the recent uptrend was China related. Certainly one could understand why. The FDA is almost opposed to new drugs in principal and China appears to welcome progress in this area. I think we can all be pleased that they are fighting this battle on two fronts. Perhaps they even have funding comming from China.
Regardless. I am happy with these developments and appreciate your sharing this information.